Select Page
  1. Home »

Press Release

Sun Pharma receives DCGI approval for Molxvir® (Molnupiravir) in India
Read more

Press Release

Sun Pharma and Philogen enter into a global Exclusive Commercialization, License, and Supply Agreement for Commercializing the specialty product FIBROMUN
Read More

The Sun Story

Watch the inspiring growth story of Sun – from humble beginnings in 1983 with just 2 employees and 5 psychiatry products to becoming the 4th largest global generic pharmaceutical company, selling over 2000 products in over 100 countries.

Subscribe on YouTube

SunPharma on Twitter

Sun Pharma Follow

Official account of world's 4th largest specialty generic pharmaceutical company. See our community guidelines: https://t.co/rYfTm9Nn1i

SunPharma_Live
sunpharma_live Sun Pharma @sunpharma_live ·
17 Sep

We’re going to be at CPHI Milan 2024! Know about our extensive API portfolio & global GMP-certified facilities and exchange ideas with us. We’re excited to explore opportunities together.

Register for the event and email api.business@sunpharma.com to schedule a meeting. See you…

Reply on Twitter 1835899233481744734 Retweet on Twitter 1835899233481744734 1 Like on Twitter 1835899233481744734 12 Twitter 1835899233481744734
sunpharma_live Sun Pharma @sunpharma_live ·
13 Sep

‘PACE & Aspire’, our annual conclave celebrates & reinforces our commitment to continuous improvement and operational excellence, recognising our teams’ extraordinary efforts in driving progress across all aspects of our manufacturing operations. Here’s a glimpse of this year’s…

Reply on Twitter 1834569706688115102 Retweet on Twitter 1834569706688115102 2 Like on Twitter 1834569706688115102 14 Twitter 1834569706688115102
sunpharma_live Sun Pharma @sunpharma_live ·
6 Sep

The U.S. Food and Drug Administration has granted Fast Track designation to MM-II (Large Liposomes of DPPC and DMPC) for the treatment of osteoarthritis knee pain. Planning for confirmatory Phase 3 clinical trials for MM- II is underway.

Read more here: https://bit.ly/4ghnsE8

Reply on Twitter 1832025789937733851 Retweet on Twitter 1832025789937733851 4 Like on Twitter 1832025789937733851 13 Twitter 1832025789937733851
sunpharma_live Sun Pharma @sunpharma_live ·
5 Sep

Our commitment to a culture of trust, forward-thinking leadership, & millennials' holistic well-being has earned us a spot among India’s 50 Best Workplaces™ for Millennials 2024 by @GPTW_India! We’re the only large-sized ‘Biotech and Pharma’ organisation to get this recognition.

Reply on Twitter 1831691072348553359 Retweet on Twitter 1831691072348553359 1 Like on Twitter 1831691072348553359 6 Twitter 1831691072348553359
sunpharma_live Sun Pharma @sunpharma_live ·
2 Sep

Every year, we honour our colleagues who have completed 25 years of service with Sun. This year, 118 awardees gathered in Mumbai to celebrate their remarkable 25-year long journey at ‘Sunmaan 2024’.

Stay tuned for stories that highlight their inspiring journeys! #WeAreSun

4

Reply on Twitter 1830597444461269355 Retweet on Twitter 1830597444461269355 1 Like on Twitter 1830597444461269355 27 Twitter 1830597444461269355
sunpharma_live Sun Pharma @sunpharma_live ·
23 Aug

We are pleased to share that we have launched the Tedizolid Phosphate tablets 200 mg in India under the brand name “STARIZO”.

Read more here: https://bit.ly/3YQoJfk

Reply on Twitter 1826963847996932472 Retweet on Twitter 1826963847996932472 9 Like on Twitter 1826963847996932472 57 Twitter 1826963847996932472
sunpharma_live Sun Pharma @sunpharma_live ·
19 Aug

Ever wondered what keeps our colleagues going? Watch them share their Sun journey in a nutshell and get inspired! #WeAreSun

Reply on Twitter 1825435955064455359 Retweet on Twitter 1825435955064455359 2 Like on Twitter 1825435955064455359 10 Twitter 1825435955064455359
Load More

Find out more

Innovation

Science is at the heart of Sun Pharma. Our scientists work closely with doctors, patients, and business development teams, to generate innovative concepts and ideas to harness market needs and synergies across therapeutic areas.

Read more

Quality

Our vision is to globalize, harmonize and simplify GxP processes to achieve a sustainable quality culture.

Read more

Careers

We hire exceptionally talented individuals, and ensure they are nurtured professionally. Our multi-dimensional work environment offers high growth opportunities through challenging roles with clear responsibilities.

Read more

Responsibility

Our CSR efforts are focused on serving and helping needy and underprivileged communities. Our priority areas include: health, education, drinking water and sanitation.

Read more
Sun Pharma offers a program for individuals who want to disclose violations of US FDA requirements related to facilities or products owned or operated by Ranbaxy prior to Sun Pharma acquisition of Ranbaxy. Continue
Top